Citations for
1ATXN3, MJD
Sodium valproate alleviates neurodegeneration in SCA3/MJD via suppressing apoptosis and rescuing the hypoacetylation levels of histone H3 and H4.
Yi J, Zhang L, Tang B, Han W, Zhou Y, Chen Z, Jia D, Jiang H.
PLoS One 8(1):e54792. doi: 10.1371/journal.pone.0054792. Epub 2013 Jan 28. 2013
2ATXN3, BAX, BCL2L1, MJD
Ataxin-3 protects cells against H2O2-induced oxidative stress by enhancing the interaction between Bcl-XL and Bax.
Zhou L, Wang H, Wang P, Ren H, Chen D, Ying Z, Wang G.
Neuroscience 243:14-21. doi: 10.1016/j.neuroscience.2013.03.047. Epub 2013 Apr 2. 2013
3ATXN3, MJD, PRKN
The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability.
Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, Djarmati A, Fantaneanu T, Paulson HL, Fon EA.
Hum Mol Genet 20(1):141-54. Epub 2010 Oct 11. 2011
4ATXN3, MJD
Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease.
Koch P, Breuer P, Peitz M, Jungverdorben J, Kesavan J, Poppe D, Doerr J, Ladewig J, Mertens J, Tüting T, Hoffmann P, Klockgether T, Evert BO, Wüllner U, Brüstle O.
Nature 480(7378):543-6. doi: 10.1038/nature10671. 2011
5ATXN3, MJD
Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3?
Alves S, Nascimento-Ferreira I, Dufour N, Hassig R, Auregan G, Nóbrega C, Brouillet E, Hantraye P, Pedroso de Lima MC, Déglon N, de Almeida LP.
Hum Mol Genet 19(12):2380-94. Epub 2010 Mar 22.PMID: 20308049 2010
6ATXN3, MJD
The (CAG)n tract of Machado-Joseph Disease gene (ATXN3): a comparison between DNA and mRNA in patients and controls.
Bettencourt C, Santos C, Montiel R, Kay T, Vasconcelos J, Maciel P, Lima M.
Eur J Hum Genet 18(5):621-3. Epub 2009 Nov 25.PMID: 19935829 2010
7ATXN3, MJD
Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease.
Alves S, Régulier E, Nascimento-Ferreira I, Hassig R, Dufour N, Koeppen A, Carvalho AL, Simőes S, de Lima MC, Brouillet E, Gould VC, Déglon N, de Almeida LP.
Hum Mol Genet 17(14):2071-83. Epub 2008 Apr 1. 2008
8MJD, ATXN3
Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3.
Haacke A, Broadley SA, Boteva R, Tzvetkov N, Hartl FU, Breuer P.
Hum Mol Genet 15(4):555-68. Epub 2006 Jan 11. 2006
9MJD, ATXN3
A multistep mutation mechanism drives the evolution of the CAG repeat at MJD/SCA3 locus.
Martins S, Calafell F, Wong VC, Sequeiros J, Amorim A.
Eur J Hum Genet 14(8):932-40. Epub 2006 May 17. 2006
10SCA1, ATXN1, SCA2, ATXN2, MJD, ATXN3, SCA6, CACNA1A, SCA7, ATXN7, SCA17, TBP, DRPLA, ATN1, SBMA, AR
Transcriptional alterations and chromatin remodeling in polyglutamine diseases.
Helmlinger D, Tora L, Devys D.
Trends Genet 22(10):562-70. Epub 2006 Sep 5. 2006
11ATXN3, MJD
Ribosomal frameshifting on MJD-1 transcripts with long CAG tracts.
Toulouse A, Au-Yeung F, Gaspar C, Roussel J, Dion P, Rouleau GA.
Hum Mol Genet 14(18):2649-60. Epub 2005 Aug 8. 2005
12FXN, FRDA, FRAXA, FMR1, FRAXE, ATXN1, SCA1, ATXN2, SCA2, ATXN3, MJD, ATXN7, SCA7, SCA6, CACNA1A, SCA17, TBP, DRPLA, ATN1, AR, SBMA, DM1, DMPK, DM2, CNBP, SCA10, ATXN10, SCA12, PPP2R2B, SCA8, ATXN8OS
Diseases of unstable repeat expansion: mechanisms and common principles.
Gatchel JR, Zoghbi HY.
Nat Rev Genet 6(10):743-55. Review. 2005
13ATXN3, MJD
The pathogenesis of Machado Joseph Disease: a high manganese/low magnesium initiated CAG expansion mutation in susceptible genotypes?
Purdey M.
J Am Coll Nutr 23(6):715S-29S. Review. 2004
14MJD, ATXN3
Gene expression profiling in ataxin-3 expressing cell lines reveals distinct effects of normal and mutant ataxin-3.
Evert BO, Vogt IR, Vieira-Saecker AM, Ozimek L, de Vos RA, Brunt ER, Klockgether T, Wullner U.
J Neuropathol Exp Neurol 62(10):1006-18. 2003
15MJD
Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities.
Li F, Macfarlan T, Pittman RN, Chakravarti D.
J Biol Chem 277(47):45004-12. Epub 2002 Sep 23. 2002
16ATN1, MJD, ATXN1
Brain regional differences in the expansion of a CAG repeat in the spinocerebellar ataxia : dentatorubral-pallidoluysian atrophy, Machado-Joseph disease, and spinocerebellar ataxia type 1.
Hashida H, et al.
Ann Neurol 41 : 505-511. 1997
17ATXN1, HD, HTT, MJD
Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias.
Trottier Y, Lutz Y, Stevanin G, Imbert G, Devys D, Cancel G, Saudou F, Weber C, David G, Tora L, et al.
Nature 378 : 403-406. 1995